E-Mail
IMAGE: HPV infection causes cells to undergo changes. If not treated these cells can, over time, become cancer cells. view more
Credit: National Cancer Institute
Today, doctors and scientists across America at National Cancer Institute (NCI)-designated cancer centers and other organizations issued a joint statement urging the nation s health care systems, physicians, parents and children, and young adults to get the human papillomavirus (HPV) vaccination back on track.
Dramatic drops in annual well visits and immunizations during the COVID-19 pandemic have caused a significant vaccination gap and lag in vital preventive services among U.S. children and adolescents especially for the HPV vaccine. The pandemic also has exacerbated health disparities, leaving Black, Indigenous and other people of color; rural; and sexual minority adolescents at even greater risk for missed doses of this cancer prevention vaccine.
St. Jude Children’s Research Hospital will commit $11.5 billion in the next six years to speed up research and treatment for children with catastrophic diseases, the Memphis institution announced Tuesday.
St. Jude’s six-year strategic plan calls for 1,400 more jobs, developing new research areas and spending $1.9 billion for construction, renovation and capital needs. This plan is really focused on accelerating progress against pediatric catastrophic diseases, said St. Jude President and CEO Dr. James Downing. It’s a massive new investment in the institution.
The investment, the largest in St. Jude’s history, will cover a range of high-priority areas for St. Jude, including childhood cancer and other catastrophic diseases in children, international initiatives and expansions in its workforce, research and campus.
St Jude targets HPV-related cancer drbicuspid.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from drbicuspid.com Daily Mail and Mail on Sunday newspapers.
Rohit Pappu, the Edwin H. Murty Professor of Engineering in the Department of Biomedical Engineering, received funds to study RNA-binding proteins that are mutated in patients with familial forms of amyotrophic lateral sclerosis (ALS).
Scientists from Washington University in St. Louis and St. Jude Children’s Research Hospital have been awarded a five-year $3.1 million grant from the National Institute of Neurological Disorders and Stroke, an affiliate of the National Institutes of Health (NIH).
Rohit Pappu, the Edwin H. Murty Professor of Engineering in the Department of Biomedical Engineering in the McKelvey School of Engineering at Washington University, and Tanja Mittag, of the St. Jude Department of Structural Biology, received the funds to study RNA-binding proteins that are mutated in patients with familial forms of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.
St Jude launches program to boost HPV cancer prevention across the globe prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.